Celularity Inc. (CELU) financial statements and ratios from SEC XBRL: revenue $26.55M (TTM), net margin -345.4%, revenue growth -51.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $26.55M |
| Net Margin | -345.4% |
| Return on Equity | 241.0% |
| Debt / Equity | -0.17 |
| Current Ratio | 0.15 |
| Revenue Growth (YoY) | -51.0% |
| EPS Growth (YoY) | 36.0% |
| EV / EBITDA | -0.2 |
| Price / Book | -0.53 |
| Price / Sales | 0.76 |
| FCF Yield | -66.1% |
| Altman Z-Score | -15.21 (distress) |
| Sector P/E (Healthcare) | 21.7 |
CELU overview · CELU earnings · CELU KPIs · CELU investor relations · CELU ownership · CELU peers · CELU filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.